A transformational new treatment for multiple sclerosis (MS) – the result of over three decades of research in Cambridge — has secured approval by the National Institute of Health and Care Excellence (NICE) for in the UK, following approval in 2013 by the EU agency responsible for regulating new drugs.


In recognition of the highly effective new treatment, the University of Cambridge has produced this video which explores the history of the drug, showing the many challenges as well as successes experienced during the course of this development.